-
Surgery alone may cure low-risk thyroid cancers, study suggests
Surgery alone might be sufficient to cure the lowest-risk thyroid cancers, a study published March 10 in The New England Journal of Medicine suggested. -
Urologic oncologist joins RWJBarnabas, Rutgers medical group
Rahuldev Bhalla, MD, a fellowship-trained board-certified urologist, joined the combined medical group of RWJBarnabas Health and Rutgers Health, the systems said March 10. -
Atrium Health building $69M radiation therapy center
Charlotte, N.C.-based Atrium Health has broken ground on a radiation therapy facility that will offer two new therapies for patients with complex tumors. -
New Jersey hospital names director of breast surgery
Neptune Township, N.J.-based Jersey Shore University Medical Center, part of Edison, N.J.-based Hackensack Meridian Health, has selected Roshani Patel, MD, to serve as medical director of breast surgery. -
City of Hope nurses to protest over patient safety concerns
Registered nurses at Duarte, Calif.-based City of Hope will hold a silent protest and press conference March 10 to protest the hospital administration’s "refusal" to address patient care and safe-staffing concerns at the cancer treatment center. -
4 recent cancer center openings, constructions
Here are four hospitals and health systems that have opened new cancer facilities or shared plans to open new centers since Feb. 3. -
UNC Health getting software to boost evidence-based cancer care
Chapel Hill, N.C.-based UNC Health will be using new software this fall to support a common high quality evidence-based standard of cancer across its entire system, it said March 8. -
How patient navigators are closing cancer health disparities in Delaware
Patient navigators have played a critical role in how Delaware has been able to lower cancer death rates and lessen racial disparities, NPR reported March 7. -
5 recent oncology partnerships
Five oncology-related partnerships formed since Feb. 15: -
Oncologists on the move
The following oncologists joined new practices, received new appointments or left roles in the last few weeks: -
Mount Sinai Medical Center to build cancer center in Miami Beach
Mount Sinai Medical Center will launch a cancer center on its main campus in Miami Beach, South Florida Hospital News reported March 7. -
Entire North Carolina cancer center board resigns after director's removal
A 15-member external advisory board for the Atrium Health Wake Forest Baptist Comprehensive Cancer Center in Winston-Salem, N.C., resigned following the unexpected removal of the center's director, the Winston-Salem Journal reported March 6. -
Women face more adverse events from targeted, immune cancer therapies than men, study finds
A study examining differences between men and women receiving immune or targeted cancer therapies found that women faced more adverse events than men, just as they face more adverse events with chemotherapy, according to the Journal of Clinical Oncology. -
Gene driving breast cancer metastasis discovered at Yale
Yale researchers discovered that the epigenetic regulator gene cat eye syndrome chromosome region candidate 2, or CECR2, is responsible for driving breast cancer metastasis. -
Researchers' warnings about 'wonder drug' top oncology stories for February
News about potential negative consequences when prescribing metformin for cancer patients was Becker's most-read oncology story in February. -
Cleveland Clinic Florida cancer center welcomes oncologist
Anatoly Nikolaev, MD, PhD, has joined the Cleveland Clinic Weston (Fla.) Maroone Cancer Center. -
Survey investigates toll of cancer care crowdfunding on survivors
The financial relief of medical crowdfunding is often accompanied by feelings of shame in asking for help, a study published in the Journal of Cancer Survivorship suggests. -
UNC Rex opens new cancer center
Raleigh, N.C.-based UNC Rex Healthcare opened a new cancer center March 1. -
1 in 7 breast cancer cases overdiagnosed, Duke study finds
About 1 in 7 breast cancer cases are overdiagnosed, a study published March 1 in the Annals of Internal Medicine found. -
FDA approves new CAR-T cell therapy for multiple myeloma
The FDA approved carvykti, a new customized, cell-based treatment from Johnson & Johnson, for the treatment of multiple myeloma, Johnson & Johnson said Feb. 28.
Page 45 of 50